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Introduction {#acn350799-sec-0001}
============

Epilepsy and intellectual disability (ID) are common neuropsychiatric disorders with an approximate prevalence of 0.3 to 2%.[1](#acn350799-bib-0001){ref-type="ref"}, [2](#acn350799-bib-0002){ref-type="ref"}, [3](#acn350799-bib-0003){ref-type="ref"}, [4](#acn350799-bib-0004){ref-type="ref"} A subgroup of cases is due to pathogenic variants in potassium channels, which, however, might also present with a range of additional neurological features, such as ataxia.[5](#acn350799-bib-0005){ref-type="ref"}, [6](#acn350799-bib-0006){ref-type="ref"}, [7](#acn350799-bib-0007){ref-type="ref"}, [8](#acn350799-bib-0008){ref-type="ref"}, [9](#acn350799-bib-0009){ref-type="ref"} The potassium channel subfamily K~V~3 consists of four subunits (K~V~3.1, K~V~3.2, K~V~3.3, and K~V~3.4) which are encoded by *KCNC1*, *KCNC2*, *KCNC3,* and *KCNC4*.[10](#acn350799-bib-0010){ref-type="ref"} Mutations in *KCNC3* are a well‐established cause of spinocerebellar ataxia type 13, whereas *KCNC2* and *KCNC4* have so far not been associated with human disease.[8](#acn350799-bib-0008){ref-type="ref"}, [9](#acn350799-bib-0009){ref-type="ref"}

The evolutionarily highly conserved voltage‐gated potassium channel K~V~3.1 is predominantly expressed in fast‐spiking neurons to enable high‐frequency firing by fast channel activation and membrane repolarization.[10](#acn350799-bib-0010){ref-type="ref"} Fast‐spiking neurons include GABAergic interneurons in the neocortex and hippocampus, Purkinje cells in cerebellum, and neurons in central auditory nuclei.[10](#acn350799-bib-0010){ref-type="ref"}, [11](#acn350799-bib-0011){ref-type="ref"} To date, only one recurrent de novo missense variant in *KCNC1* (c.959G \> A, p.Arg320His) has been reported as a cause of progressive myoclonus epilepsy and ataxia (MEAK; OMIM \#616187). The respective phenotype is similar to Unverricht‐Lundborg disease.[12](#acn350799-bib-0012){ref-type="ref"}, [13](#acn350799-bib-0013){ref-type="ref"}, [14](#acn350799-bib-0014){ref-type="ref"}, [15](#acn350799-bib-0015){ref-type="ref"} Subsequently, one nonsense variant (c.1015C \> T, p.Arg339\*) has been identified in three affected members of single family with ID without seizures.[16](#acn350799-bib-0016){ref-type="ref"} Here, we report three new pathogenic de novo missense variants in *KCNC1* in five unrelated patients. The provided clinical information adds to the phenotypic delineation of *KCNC1*‐related disease.

Patients, Materials, and Methods {#acn350799-sec-0002}
================================

Clinical and genetic investigations {#acn350799-sec-0003}
-----------------------------------

Patients were evaluated by neurologists and referred for diagnostic whole exome sequencing (WES) at different centers. The methods for WES and Sanger sequencing have been previously described.[17](#acn350799-bib-0017){ref-type="ref"}, [18](#acn350799-bib-0018){ref-type="ref"} Written informed consent to participate in this study was obtained from all patients or their parents.

Functional analysis {#acn350799-sec-0004}
-------------------

The functional evaluation of identified *KCNC1* variants was performed using two‐electrode voltage‐clamp recordings as previously described.[13](#acn350799-bib-0013){ref-type="ref"} Briefly, the three missense variants were introduced in the human *KCNC1* cDNA (NM_004976) cloned in a pCMV Entry Vector (OriGene Technologies, USA) using the Quick Change Method (Stratagene, USA). The plasmids were linearized and in vitro transcription was performed using T7 RNA Polymerase (Roche Diagnostics GmbH, Germany). *Xenopus laevis* oocytes (EcoCyte Bioscience, Germany) were washed in OR2 and incubated in Barth solution with gentamycin. Fifty‐nanoliters of cRNA (2 *µ*g/µL) was injected using Robooinject® (Multichannel Systems, Germany) and stored at 16°C. Potassium currents were recorded after 2--3 days at room temperature (21--23°C) on Roboocyte2® (Multichannel Systems, Germany). Data analysis and graphical illustrations were achieved using Roboocyte2+ (Multichannel Systems, Germany), Excel (Microsoft, USA), and Graphpad Software (GraphPad Software, USA). Statistical evaluation for multiple comparisons (*P* \< 0.05) was conducted using one‐way ANOVA on ranks with Dunn\'s post hoc test.

Results {#acn350799-sec-0005}
=======

Genetic testing {#acn350799-sec-0006}
---------------

WES revealed three different heterozygous missense variants in *KCNC1* (NM_001112741.1) in five unrelated patients. Patient 1 carries c.623G \> A, p.Cys208Tyr, patient 2 c.1196C \> T, p.Thr399Met, and patients 3, 4, and 5 c.1262C \> T, p.Ala421Val. All variants are absent from public databases \[1000 Genomes project, Genome Aggregation Database (gnomAD 2.0.2), Exome Aggregation Consortium (ExAC 0.3.1)\]. In line with a postulated de novo status, none of the variants was detected in DNA extracted from parental whole blood (Fig. [1](#acn350799-fig-0001){ref-type="fig"}A). Additional rare variants identified in patients 1, 2, and 3 are provided in Table [S1](#acn350799-sup-0001){ref-type="supplementary-material"}. We cannot entirely rule out a potential contribution of these changes to the observed phenotypes. However, to the best of our knowledge there is currently no evidence supporting a functional relevance and putative disease association of these additional changes.

![(A) Pedigrees of the five unrelated affected individuals (closed symbols) with de novo KCNC1 variants and status of healthy family members (open symbols). wt indicates for wild type. (B) Graphical illustration of the K~V~3.1 channel demonstrates the domain structures. The positions of the identified variants (Cys208Tyr, Thr399Met, Ala421Val) and the previously published variants (Arg320His and Arg339\*) are highlighted with stars. The plus sign illustrates the positively charged arginine in the voltage‐sensing S4 segment.[21](#acn350799-bib-0021){ref-type="ref"} (C) Amino acid sequences across different species indicate that the variants are localized in highly conserved regions. (D) Images of patient 2 at 11 years of age show hypertelorism, long palpebral fissures, broad nose, large ears, diastema, small chin, and sandal gap. The hands of patient 2 do not have any dysmorphic features.](ACN3-6-1319-g001){#acn350799-fig-0001}

Clinical phenotypes {#acn350799-sec-0007}
-------------------

### Patient 1 (Cys208Tyr) {#acn350799-sec-0008}

A 23‐year‐old German woman reported that mild tremor‐like symptoms began on both hands at the age of 2 years. Her psychomotor development was normal. Neurological examination revealed mild and nonprogressive constant high‐frequency action and postural myoclonus (or irregular tremor) on both arms with dystonic features on the right hand and arm with constant hyperextension of the fourth and fifth finger and reduced arm swing during gait (Video [S1](#acn350799-sup-0002){ref-type="supplementary-material"}). The patient initially received diagnostics and various treatments for tremor without success (see below), and the quite jerky aspect of the irregular movements is more reminiscent of myoclonus in our opinion. An electromyographical (EMG) recording which might have helped to distinguish between tremor and myoclonus has not been performed. Copper metabolism, F‐dopa PET, and MRI scans of the brain and multiple EEG recordings were normal. Treatment trials with beta blockers, levodopa, and primidone were unsuccessful. Epileptic seizures were not reported.

### Patient 2 (Thr399Met) {#acn350799-sec-0009}

An 18‐year‐old German male works in a sheltered workshop and shows some articulation difficulties. When he was last examined at the age of 11 years, he was attending special school. He was diagnosed with mild to moderate intellectual disability and showed behavioral abnormalities, for example, difficulties socializing with other children. Motor development was slightly delayed, but his language was severely affected with first words by the age of 5 years. Dysmorphic features are shown in Figure [1](#acn350799-fig-0001){ref-type="fig"}D. There were neither congenital malformations nor any reported seizures. Neurological examination was unremarkable. EEG and MRI scan of the brain were normal.

### Patient 3 (Ala421Val) {#acn350799-sec-0010}

Patient 3 is a 5‐year‐old Croatian female in whom seizures (focal onset impaired awareness seizures, tonic‐clonic and myoclonic seizures) were first noted at 5 months of age and occurred up to 40 times per day. First generalized tonic‐clonic seizures started at the age of 2 years. Treatments with levetiracetam, zonisamide, and carbamazepine were unsuccessful. Finally, a combination therapy with clobazam and topiramate reduced her seizure frequency to 1--2 per month. She had global developmental delay and mild gait ataxia, which was so far nonprogressive. The EEG showed multifocal epileptic discharges and irregular spike‐wave complexes with polyspikes followed by bilateral synchronic 2/s spike‐wave activities. Cerebral MRI was normal.

### Patient 4 (Ala421Val) {#acn350799-sec-0011}

Patient 4, a 2‐year‐old female of Turkish origin, first presented with febrile seizures 3 weeks after birth. Seizures then occurred 15--35 times per day and lasted for 5--35 sec with even higher seizure frequencies during episodes with high fever, which did not respond to levetiracetam or valproate. She mostly had myoclonic absence seizures (Video [S1](#acn350799-sup-0002){ref-type="supplementary-material"}), and less frequently myoclonic seizures without impaired awareness or absence seizures without myoclonus. During the myoclonic absence seizure, her eyes rolled upwards and both her proximal arms twitched for a few seconds. Her global development was delayed. She is now able to walk and vocalize but does not speak. Twenty‐four‐hour‐EEG showed normal background activity and multiple seizure episodes with rhythmic bifrontal 2--3/s spike‐wave discharges for 6--20 sec. Cerebral MRI was unremarkable (Fig. [S2](#acn350799-sup-0001){ref-type="supplementary-material"}).

### Patient 5 (Ala421Val) {#acn350799-sec-0012}

This 2‐year‐old Chinese‐French male showed first myoclonic seizures at 5 months of age. The initial seizure frequency was 1--2 per day, which increased to 60--70 per day after 4 months. Treatment with valproate, levetiracetam, and clonazepam reduced his seizure frequency dramatically to once per month. He had predominantly myoclonic absence seizures (Video [S1](#acn350799-sup-0002){ref-type="supplementary-material"} with face covered) presenting with rapid eyelid myoclonia accompanied by twitching of proximal arms. The myoclonus was mostly on the left side, but occasionally occurred on both arms. In addition, he also had absences without myoclonus lasting for approximately 10 sec. At 8 months, he had two generalized tonic‐clonic seizures. The EEG showed episodes with generalized rhythmic discharges of 2--4 Hz, sometimes only as waves, sometimes as spike‐waves, lasting up to 15 sec and often accompanied by myoclonic movements visible in the electromyographic trace (Fig. [S3](#acn350799-sup-0001){ref-type="supplementary-material"}). His development was delayed; he is now able to speak ten simple words, but cannot stand alone without any help. Cerebral MRI did not show any abnormalities.

Functional consequences of *KCNC1* variants {#acn350799-sec-0013}
-------------------------------------------

Current amplitudes recorded in oocytes expressing either of the three mutant channels were barely detectable and similar to water‐injected controls (Fig. [2](#acn350799-fig-0002){ref-type="fig"}A and [2](#acn350799-fig-0002){ref-type="fig"}). Coexpression of wild type (WT) with mutant channels indicated dominant‐negative loss‐of‐function effects with a significant decrease in K^+^ current amplitudes of approximately 68% and 48% for Thr399Met and Ala421Val mutant channels compared to WT alone (Fig. [2](#acn350799-fig-0002){ref-type="fig"}C and D), whereas coexpression of Cys208Tyr mutant and WT channels did not cause a significant amplitude reduction. The activation curve showed a hyperpolarizing shift when WT channels were coexpressed with Ala421Val mutant channels in comparison to WT channels alone (Fig. [2](#acn350799-fig-0002){ref-type="fig"}E), whereas Cys208Tyr channels did not show any significant difference. Thr399Met showed a strong dominant‐negative effect on the WT which impeded the evaluation of further gating parameters.

![Functional consequences of the identified *KCNC1* variants. (A) Representative traces of K~V~3.1 currents recorded in *Xenopus laevis* oocytes expressing the wild type (WT) and the single‐site variants (Cys208Tyr, Thr399Met, Ala421Val) in response to the voltage steps from − 60 mV to + 60 mV. (B) Relative current amplitudes of oocytes injected with the WT (*n* = 23), Cys208Tyr (*n* = 8), Thr399Met (*n* = 14), and Ala421Val (*n* = 8) mutant channels (Dunn's test, *P* \< 0.05). Mean current amplitudes of currents elicited by a + 40 mV voltage step were analyzed between 0.4 and 0.5 msec and normalized to the mean value of WT channels recorded on the same day. (C) Representative current traces recorded in oocytes that were coinjected with WT cRNA and either water or a mutant cRNA in a 1:1 ratio. (D) Relative current amplitudes recorded from oocytes coexpressing WT and mutant channels (WT + H~2~O (*n* = 36), WT + Cys208Tyr (*n* = 8), WT + Thr399Met (*n* = 6), WT + Ala421Val (*n* = 27)) were normalized to the mean current amplitude of oocytes coinjected with the WT channel and water recorded on the same day (Dunn\'s test, *P* \< 0.05). (E) Mean voltage‐dependent activation of K~V~3.1 channel for WT (*n* = 20), WT + Cys208Tyr (*n* = 5) and WT + Ala421Val (n = 10) channels. Lines illustrate Boltzmann Function fit to the data points. The activation curve of WT + Ala421Val channels showed a significant shift to more hyperpolarized potentials in comparison to WT channels alone. All data are shown as means ± SEM. The following symbols were used for statistical differences: ^\*^ *P* \< 0.05, ^\*\*^ *P* \< 0.01 and ns for not significant.](ACN3-6-1319-g002){#acn350799-fig-0002}

Discussion {#acn350799-sec-0014}
==========

We here identified three new de novo missense variants in *KCNC1* in five unrelated individuals presenting with different clinical phenotypes compared to previously reported *KCNC1* patients. Patient 1 (Cys208Tyr) exhibited nonprogressive, relatively mild, action‐induced myoclonus (or irregular tremor) as the only clinical sign without any cerebellar, epileptic, or cognitive symptoms. In contrast, MEAK patients (Arg320His) had a more severe and progressive action‐induced myoclonus, epilepsy, and ataxia leading to wheelchair dependency in 11 of 22 published patients by the age of approximately 17 years.[13](#acn350799-bib-0013){ref-type="ref"}, [14](#acn350799-bib-0014){ref-type="ref"}, [15](#acn350799-bib-0015){ref-type="ref"} The phenotype of patient 2 (Thr399Met), who showed ID and dysmorphic features, is more similar to the family reported by Poirier et al*.* in which three affected members carried the nonsense mutation Arg339\*.[16](#acn350799-bib-0016){ref-type="ref"} All three had similar dysmorphic features, which however differed from those observed in patient 2 (Fig. [1](#acn350799-fig-0001){ref-type="fig"}D, Table [1](#acn350799-tbl-0001){ref-type="table"}). Compared to MEAK patients, also the three unrelated patients (3, 4, and 5) carrying the Ala421Val variant presented with different symptoms, neither showing myoclonus, but myoclonic and absence seizures and developmental delay. The presence of ataxia is difficult to judge as all three are still very young. While this study was underway, the change Ala421Val has been submitted to ClinVar by another group, indicating that it might represent a more frequent recurrent cause of ID and seizures.[19](#acn350799-bib-0019){ref-type="ref"}

###### 

Clinical features of *KCNC1* patients

                               This publication                        This publication                                                                       This publication                                                                                             This publication                                                        This publication                                                                       MEAK patients[13](#acn350799-bib-0013){ref-type="ref"}, [14](#acn350799-bib-0014){ref-type="ref"}, [15](#acn350799-bib-0015){ref-type="ref"}   Poirier et al. 2017
  ---------------------------- --------------------------------------- -------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------- -------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------
  Patient                      Patient 1                               Patient 2                                                                              Patient 3                                                                                                    Patient 4                                                               Patient 5                                                                              22 cases                                                                                                                                       3 cases
  Variant                      **c.623G \> A, p.Cys208Tyr**            **c.1196C \> T, p.Thr399Met**                                                          **c.1262C \> T, p.Ala421Val**                                                                                **c.1262C \> T, p.Ala421Val**                                           **c.1262C \> T, p.Ala421Val**                                                          **c.959G \> A, p.Arg320His**                                                                                                                   **c.1015C \> T, p.Arg339\***
  Inheritance                  De novo                                 De novo                                                                                De novo                                                                                                      De novo                                                                 De novo                                                                                De novo (14), 3 families (8)                                                                                                                   Paternal
  Age at onset (current age)   2 years (23 years)                      1--2 years (18 years)                                                                  5 months (5 years)                                                                                           3 weeks (2 years)                                                       5 months (2 years)                                                                     3--15 years                                                                                                                                    1--2 years
  First sign                   Myoclonus or \"tremor\"                 Developmental delay                                                                    Myoclonic seizures                                                                                           Febrile seizures                                                        Myoclonic seizures                                                                     Myoclonus or \"tremor\"                                                                                                                        Developmental delay
  Seizures                     No                                      No                                                                                     Tonic‐clonic, focal onset impaired awareness, myoclonic, generalized                                         Myoclonic absence, myoclonic, absence                                   Myoclonic absence, absence, generalized                                                Tonic‐clonic, myoclonic, generalized                                                                                                           No
  Action‐induced Myoclonus     Mild, nonprogressive                    No                                                                                     No                                                                                                           No                                                                      No                                                                                     Severe, progressive                                                                                                                            No
  EEG                          Normal                                  Normal                                                                                 Normal background, irregular spike‐wave activity with polyspikes and rhythmic generalized 2 Hz spike‐waves   Normal background activity, generalized 2--3 Hz spike‐wave discharges   Normal background, generalized 2--4 Hz rhythmic slow waves and sometimes spike‐waves   Normal background, generalized polyspike, polyspike‐wave and spike‐wave (13), unknown (9)                                                      Normal
  Brain MRI                    Normal                                  Normal                                                                                 Normal                                                                                                       Normal                                                                  Normal                                                                                 Global symmetrical cerebellar atrophy (13) unknown (9)                                                                                         Normal
  Ataxia                       No                                      No                                                                                     Mild, so far nonprogressive                                                                                  Balancing difficulties possible                                         No                                                                                     Progressive                                                                                                                                    No
  Developmental delay          No                                      Yes                                                                                    Yes                                                                                                          Yes                                                                     Yes                                                                                    Mild (2), no (20)                                                                                                                              Yes
  Cognitive Decline            Possible memory deficits (MOCA 28/30)   No                                                                                     No                                                                                                           No                                                                      No                                                                                     Yes (11), possible (2), no (7)                                                                                                                 No
  Dysmorphism                  No                                      Hypertelorism, long palpebral fissures, broad nose, large ears, diastema, small chin   No                                                                                                           No                                                                      No                                                                                     No                                                                                                                                             Prognathism, protruding ears, short philtrum, fetal pads, epicanthal folds, ptosis
  Others                       Dystonia, scoliosis                     Frequent diarrhea and vomiting                                                         Mild muscular hypotonia                                                                                      Mild muscular hypotonia                                                 Cannot walk yet                                                                        Wheelchair‐dependent (11)                                                                                                                      Clinodactyly of the fifth finger (1)

John Wiley & Sons, Ltd

Functional studies demonstrated a complete loss‐of‐function for all three variants with a significant dominant‐negative effect on WT channels for Thr399Met and Ala421Val (Fig. [2](#acn350799-fig-0002){ref-type="fig"}A--D). Similar to the previously published variant Arg320His, Ala421Val caused a hyperpolarizing shift of the activation curve when coexpressed with WT, which was not observed for Cys208Tyr (Fig. [2](#acn350799-fig-0002){ref-type="fig"}E).[13](#acn350799-bib-0013){ref-type="ref"} In contrast to the haploinsufficiency of the truncating variant in the previously described family with ID, the variant Thr399Met, also causing ID alone, showed a pronounced dominant‐negative effect.[16](#acn350799-bib-0016){ref-type="ref"} Our current data do thus not reveal a clear correlation between the electrophysiological properties of mutant channels and clinical phenotypes. It is striking, however, that both recurring variants (Arg320His and Ala421Val) cause a different but homogeneous phenotype each, indicating specific effects of the variants themselves, despite their similar biophysical properties. Further functional characterizations in neuronal cells are needed to shed more light on the cellular and network mechanisms underlying the pathological effect of the variants on the nervous system.

K~V~3.1 is prominently expressed in inhibitory GABAergic interneurons in which these channels enable high‐frequency firing by a rapid membrane repolarization.[10](#acn350799-bib-0010){ref-type="ref"} The identified variants thus probably lead to impaired firing of GABAergic interneurons predicting neuronal disinhibition as the underlying disease mechanism. Patients 3 and 5 were both treated with benzodiazepines. Their effect on GABA neurotransmitters, enhancing the inhibitory effect on neurons might have played a critical role in reducing the patients\' seizure frequencies. Also Oliver et al described that clonazepam beside valproate was most effective in MEAK patients.[14](#acn350799-bib-0014){ref-type="ref"} Another more specific therapeutic strategy might be to directly activate mutant heterotetrameric K~V~3 channels. The feasibility of such an approach with a compound called RE01 has been recently reported in vitro.[20](#acn350799-bib-0020){ref-type="ref"}

In conclusion, we provide evidence that de novo variants in *KCNC1* cause more diverse phenotypes than described so far, such as nonprogressive myoclonus (or tremor) alone, intellectual disability, or epilepsy with myoclonic, absence and generalized tonic‐clonic seizures with developmental delay.
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**Figure S1.** Brain imaging, X‐ray and EEG of patient 1 with a Cys208Tyr variant.

**Figure S2.** Brain imaging and EEG of patient 4 with a Ala421Val variant.

**Figure S3.** EEG‐electromyographic (EMG) recording of patient 5 with a Ala421Val variant.

**Table S1.** Identified rare variants in patients 1, 2, and 3.

###### 

Click here for additional data file.

###### 

**Video S1.** The supplementary video shows action myoclonus in patient 1 and myoclonus absence seizures in patients 4 and 5.

###### 

Click here for additional data file.
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